Carolin Brinkmann

3PUBLICATIONS
3CO-AUTHORS
PharmacogenomicsSocial epidemiologyMultimorbidity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 08, 2025
Cost-utility analysis of 177Lu-PSMA-617 radioligand therapy in second-line and third-line treatment for metastatic castration-resistant prostate cancer (mCRPC) in Germany.

Carolin Brinkmann, Richard P Baum, Tom Stargardt

|Apr 16, 2025
Does timing matter? The role of health information shocks in measuring willingness to pay.

Carolin Brinkmann, Sebastian Neumann-Böhme, Werner B F Brouwer

|Sep 20, 2022
[Cost-Effectiveness of Case and Care Management in Older Populations in Germany: a Systematic Literature Review].

Carolin Brinkmann, Marija Radic, Lysann Kasprick

Pageof 1